Relative functions of Gαs and its extra-large variant XLαs in the endocrine system

Hormone and Metabolic Research

Volumn 44, Issue 10, 2012, Pages 732-740

  Bastepe, M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

bone; hypocalcemia; hypogonadism; hypothyroidism; parathyroid hormone

Indexed keywords

CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT XL ALPHA; GUANOSINE TRIPHOSPHATASE; PARATHYROID HORMONE; PROTEIN VARIANT; SYNTAXIN 16; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ALBRIGHT SYNDROME; CATALYSIS; CHROMOSOME 20; DNA SEQUENCE; ENDOCRINE SYSTEM; ENZYME ACTIVITY; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; HUMAN; HUMAN DEVELOPMENT; NONHUMAN; PATHOGENESIS; POINT MUTATION; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOHYPOPARATHYROIDISM; PSEUDOPSEUDOHYPOPARATHYROIDISM; REVIEW; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; ANIMALS; DISEASE; ENDOCRINE SYSTEM; EXONS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; MUTATION;

MAMMALIA;

EID: 84866094226     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1316331     Document Type: Review

References (118)

1. Weinstein L S, Gejman P V, Friedman E, Kadowaki T, Collins R M, Gershon E S, Spiegel A M. Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc Natl Acad Sci USA: 1990; 87 8287 8290
2. Patten J L, Johns D R, Valle D, Eil C, Gruppuso P A, Steele G, Smallwood P M, Levine M A. Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. New Engl J Med: 1990; 322 1412 1419
3. Cabrera-Vera T M, Vanhauwe J, Thomas T O, Medkova M, Preininger A, Mazzoni M R, Hamm H E. Insights into G protein structure, function, and regulation. Endocr Rev: 2003; 24 765 781
4. Spiegel A M. Introduction to G-protein-coupled signal transduction and human disease. In: Spiegel A M. (ed.) G proteins, receptors, and disease. Totowa, New Jersey Humana Press: 1998; 1 21
5. Kozasa T, Itoh H, Tsukamoto T, Kaziro Y. Isolation and characterization of the human Gsa gene. Proc Natl Acad Sci USA: 1988; 85 2081 2085
6. Gejman P V, Weinstein L S, Martinez M, Spiegel A M, Cao Q, Hsieh W T, Hoehe M R, Gershon E S. Genetic mapping of the Gs-a subunit gene (GNAS1) to the distal long arm of chromosome 20 using a polymorphism detected by denaturing gradient gel electrophoresis. Genomics: 1991; 9 782 783
7. Rao V V, Schnittger S, Hansmann I. G protein Gs alpha (GNAS 1), the probable candidate gene for Albright hereditary osteodystrophy, is assigned to human chromosome 20q12-q13.2. Genomics: 1991; 10 257 261
8. Levine M A, Modi W S, O'Brien S J. Mapping of the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase (GNAS1) to 20q13.2-q13.3 in human by in situ hybridization. Genomics: 1991; 11 478 479
9. sa gene. Proc Natl Acad Sci USA: 1998; 95 8715 8720
10. Albright F, Burnett C H, Smith P H, Parson W. Pseudohypoparathyroidism - an example of "Seabright-Bantam syndromeo" Endocrinology: 1942; 30 922 932
11. Long D N, McGuire S, Levine M A, Weinstein L S, Germain-Lee E L. Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity. J Clin Endocrinol Metab: 2007; 92 1073 1079
12. Mouallem M, Shaharabany M, Weintrob N, Shalitin S, Nagelberg N, Shapira H, Zadik Z, Farfel Z. Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gsalpha. Clin Endocrinol (Oxf): 2008; 68 233 239
13. Levine M A, Downs R W Jr, Moses A M, Breslau N A, Marx S J, Lasker R D, Rizzoli R E, Aurbach G D, Spiegel A M. Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Am J Med: 1983; 74 545 556
14. Mallet E, Carayon P, Amr S, Brunelle P, Ducastelle T, Basuyau J P, de Menibus C H. Coupling defect of thyrotropin receptor and adenylate cyclase in a pseudohypoparathyroid patient. J Clin Endocrinol Metab: 1982; 54 1028 1032
15. Wolfsdorf J I, Rosenfield R L, Fang V S, Kobayashi R, Razdan A K, Kim M H. Partial gonadotrophin-resistance in pseudohypoparathyroidism. Acta Endocrinol (Copenh): 1978; 88 321 328
16. Mantovani G, Maghnie M, Weber G, De Menis E, Brunelli V, Cappa M, Loli P, Beck-Peccoz P, Spada A. Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type ia: new evidence for imprinting of the Gs alpha gene. J Clin Endocrinol Metab: 2003; 88 4070 4074
17. Germain-Lee E L, Groman J, Crane J L, Jan de Beur S M, Levine M A. Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance. J Clin Endocrinol Metab: 2003; 88 4059 4069
18. Albright F, Forbes A P, Henneman P H. Pseudo-pseudohypoparathyroidism. Trans Assoc Am Physicians: 1952; 65 337 350
19. Levine M A, Ahn T G, Klupt S F, Kaufman K D, Smallwood P M, Bourne H R, Sullivan K A, Van Dop C. Genetic deficiency of the alpha subunit of the guanine nucleotide-binding protein Gs as the molecular basis for Albright hereditary osteodystrophy. Proc Natl Acad Sci USA: 1988; 85 617 621
20. Patten J L, Levine M A. Immunochemical analysis of the a-subunit of the stimulatory G-protein of adenylyl cyclase in patients with Albright's hereditary osteodystrophy. J Clin Endocrinol Metab: 1990; 71 1208 1214
21. Carter A, Bardin C, Collins R, Simons C, Bray P, Spiegel A. Reduced expression of multiple forms of the a subunit of the stimulatory GTP-binding protein in pseudohypoparathyroidism type Ia. Proc Natl Acad Sci USA: 1987; 84 7266 7269
22. Davies A J, Hughes H E. Imprinting in Albright's hereditary osteodystrophy. J Med Genet: 1993; 30 101 103
23. Farfel Z, Brothers V M, Brickman A S, Conte F, Neer R, Bourne H R. Pseudohypoparathyroidism: inheritance of deficient receptor-cyclase coupling activity. Proc Natl Acad Sci USA: 1981; 78 3098 3102
24. Linglart A, Carel J C, Garabedian M, Le T, Mallet E, Kottler M L. GNAS1 Lesions in Pseudohypoparathyroidism Ia and Ic: Genotype Phenotype Relationship and Evidence of the Maternal Transmission of the Hormonal Resistance. J Clin Endocrinol Metab: 2002; 87 189 197
25. Linglart A, Mahon M J, Kerachian M A, Berlach D M, Hendy G N, Jüppner H, Bastepe M. Coding GNAS mutations leading to hormone resistance impair in vitro agonist- and cholera toxin-induced adenosine cyclic 3,5-monophosphate formation mediated by human XLas. Endocrinology: 2006; 147 2253 2262
26. Thiele S, de Sanctis L, Werner R, Grotzinger J, Aydin C, Jüppner H, Bastepe M, Hiort O. Functional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type Ic defines a new subgroup of pseudohypoparathyroidism affecting selectively Gsalpha-receptor interaction. Hum Mutat: 2011; 32 653 660
27. Liu J, Litman D, Rosenberg M, Yu S, Biesecker L, Weinstein L. A GNAS1 imprinting defect in pseudohypoparathyroidism type IB. J Clin Invest: 2000; 106 1167 1174
28. Levine MA. Pseudohypoparathyroidism. In: Bilezikian J P, Raisz L G, Rodan G A. (eds.). Principles of Bone Biology. New York Academic Press: 2002; 2 1137 1163
29. Bastepe M, Pincus J E, Sugimoto T, Tojo K, Kanatani M, Azuma Y, Kruse K, Rosenbloom A L, Koshiyama H, Jüppner H. Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type Ib and the associated methylation defect at exon A/B: evidence for a long-range regulatory element within the imprinted GNAS1 locus. Hum Mol Genet: 2001; 10 1231 1241
30. Liu J, Erlichman B, Weinstein L S. The stimulatory G protein a-subunit Gsa is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types 1A and 1B. J Clin Endocrinol Metabol: 2003; 88 4336 4341
31. Bastepe M, Lane A H, Jüppner H. Paternal uniparental isodisomy of chromosome 20q (patUPD20q) - and the resulting changes in GNAS1 methylation - as a plausible cause of pseudohypoparathyroidism. Am J Hum Genet: 2001; 68 1283 1289
32. Jüppner H, Schipani E, Bastepe M, Cole DE C, Lawson M L, Mannstadt M, Hendy G N, Plotkin H, Koshiyama H, Koh T, Crawford J D, Olsen B R, Vikkula M. The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. Proc Natl Acad Sci USA: 1998; 95 11798 11803
33. de Nanclares G P, Fernandez-Rebollo E, Santin I, Garcia-Cuartero B, Gaztambide S, Menendez E, Morales M J, Pombo M, Bilbao J R, Barros F, Zazo N, Ahrens W, Jüppner H, Hiort O, Castano L, Bastepe M. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy. J Clin Endocrinol Metab: 2007; 92 2370 2373
34. Unluturk U, Harmanci A, Babaoglu M, Yasar U, Varli K, Bastepe M, Bayraktar M. Molecular diagnosis and clinical characterization of pseudohypoparathyroidism type-Ib in a patient with mild Albright's hereditary osteodystrophy-like features, epileptic seizures, and defective renal handling of uric acid. Am J Med Sci: 2008; 336 84 90
35. Mariot V, Maupetit-Mehouas S, Sinding C, Kottler M L, Linglart A. A maternal epimutation of GNAS leads to Albright osteodystrophy and parathyroid hormone resistance. J Clin Endocrinol Metab: 2008; 93 661 665
36. Mantovani G, de Sanctis L, Barbieri A M, Elli F M, Bollati V, Vaira V, Labarile P, Bondioni S, Peverelli E, Lania A G, Beck-Peccoz P, Spada A. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients. J Clin Endocrinol Metab: 2010; 95 651 658
37. Sanchez J, Perera E, Jan de Beur S, Ding C, Dang A, Berkovitz G D, Levine M A. Madelung-like deformity in pseudohypoparathyroidism type 1b. J Clin Endocrinol Metab: 2011; 96 E1507 E1511
38. Bastepe M, Fröhlich L F, Hendy G N, Indridason O S, Josse R G, Koshiyama H, Körkkö J, Nakamoto J M, Rosenbloom A L, Slyper A H, Sugimoto T, Tsatsoulis A, Crawford J D, Jüppner H. Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS. J Clin Invest: 2003; 112 1255 1263
39. Linglart A, Gensure R C, Olney R C, Jüppner H, Bastepe M. A Novel STX16 Deletion in Autosomal Dominant Pseudohypoparathyroidism Type Ib Redefines the Boundaries of a cis-Acting Imprinting Control Element of GNAS. Am J Hum Genet: 2005; 76 804 814
40. Bastepe M, Fröhlich L F, Linglart A, Abu-zahra H S, Tojo K, Ward L M, Jüppner H. Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type-Ib. Nat Genet: 2005; 37 25 37
41. Chillambhi S, Turan S, Hwang D Y, Chen H C, Jüppner H, Bastepe M. Deletion of the Noncoding GNAS Antisense Transcript Causes Pseudohypoparathyroidism Type Ib and Biparental Defects of GNAS Methylation in cis. J Clin Endocrinol Metab: 2010; 95 3993 4002
42. Landis C A, Masters S B, Spada A, Pace A M, Bourne H R, Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature: 1989; 340 692 696
43. Kalfa N, Lumbroso S, Boulle N, Guiter J, Soustelle L, Costa P, Chapuis H, Baldet P, Sultan C. Activating mutations of Gsalpha in kidney cancer. J Urol: 2006; 176 891 895
44. Nault J C, Fabre M, Couchy G, Pilati C, Jeannot E, Tran Van Nhieu J, Saint-Paul M C, De Muret A, Redon M J, Buffet C, Salenave S, Balabaud C, Prevot S, Labrune P, Bioulac-Sage P, Scoazec J Y, Chanson P, Zucman-Rossi J. GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. J Hepatol: 2012; 56 184 191
45. Bejar R, Stevenson K, Abdel-Wahab O, Galili N, Nilsson B, Garcia-Manero G, Kantarjian H, Raza A, Levine R L, Neuberg D, Ebert B L. Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med: 2011; 364 2496 2506
46. McCune D. Osteitis fibrosa cystica; the case of a nine-year old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child: 1936; 52 743 744
47. Albright F, Butler A, Hampton A, Smith P. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females. New Engl J Med: 1937; 216 727 746
48. Weinstein L S, Shenker A, Gejman P V, Merino M J, Friedman E, Spiegel A M. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. New Engl J Med: 1991; 325 1688 1695
49. Schwindinger W F, Francomano C A, Levine M A. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA: 1992; 89 5152 5156
50. Happle R. The McCune-Albright syndrome: a lethal gene surviving by mosaicism. Clin Genet: 1986; 29 321 324
51. Idowu B D, Al-Adnani M, O'Donnell P, Yu L, Odell E, Diss T, Gale R E, Flanagan A M. A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone. Histopathology: 2007; 50 691 704
52. Ischia R, Lovisetti-Scamihorn P, Hogue-Angeletti R, Wolkersdorfer M, Winkler H, Fischer-Colbrie R. Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5-HT1B receptor antagonist activity. J Biol Chem: 1997; 272 11657 11662
53. Kehlenbach R H, Matthey J, Huttner W B. XLas is a new type of G protein (Erratum in Nature 1995; 375: 253). Nature: 1994; 372 804 809
54. Swaroop A, Agarwal N, Gruen J R, Bick D, Weissman S M. Differential expression of novel Gs alpha signal transduction protein cDNA species. Nucleic Acids Res: 1991; 19 4725 4729
55. sa mRNA. J Biol Chem: 1990; 265 8458 8462
56. Hayward B, Bonthron D. An imprinted antisense transcript at the human GNAS1 locus. Hum Mol Genet: 2000; 9 835 841
57. Wroe S F, Kelsey G, Skinner J A, Bodle D, Ball S T, Beechey C V, Peters J, Williamson C M. An imprinted transcript, antisense to Nesp, adds complexity to the cluster of imprinted genes at the mouse Gnas locus. Proc Natl Acad Sci USA: 2000; 97 3342 3346
58. Hayward B E, Moran V, Strain L, Bonthron D T. Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins. Proc Natl Acad Sci USA: 1998; 95 15475 15480
59. Peters J, Wroe S F, Wells C A, Miller H J, Bodle D, Beechey C V, Williamson C M, Kelsey G. A cluster of oppositely imprinted transcripts at the Gnas locus in the distal imprinting region of mouse chromosome 2. Proc Natl Acad Sci USA: 1999; 96 3830 3835
60. Hayward B, Kamiya M, Strain L, Moran V, Campbell R, Hayashizaki Y, Bronthon D T. The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins. Proc Natl Acad Sci USA: 1998; 95 10038 10043
61. Liu J, Yu S, Litman D, Chen W, Weinstein L. Identification of a methylation imprint mark within the mouse gnas locus. Mol Cell Biol: 2000; 20 5808 5817
62. Zheng H, Radeva G, McCann J A, Hendy G N, Goodyer C G. Gas transcripts are biallelically expressed in the human kidney cortex: implications for pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab: 2001; 86 4627 4629
63. Campbell R, Gosden C M, Bonthron D T. Parental origin of transcription from the human GNAS1 gene. J Med Genet: 1994; 31 607 614
64. Hayward B, Barlier A, Korbonits M, Grossman A, Jacquet P, Enjalbert A, Bonthron D. Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly. J. Clin. Invest: 2001; 107 R31 R36
65. Mantovani G, Ballare E, Giammona E, Beck-Peccoz P, Spada A. The Gsalpha Gene: Predominant Maternal Origin of Transcription in Human Thyroid Gland and Gonads. J Clin Endocrinol Metab: 2002; 87 4736 4740
66. Puzhko S, Goodyer C G, Mohammad A K, Canaff L, Misra M, Jüppner H, Bastepe M, Hendy G N. Parathyroid hormone signaling via Galphas is selectively inhibited by an NH(2)-terminally truncated Galphas: Implications for pseudohypoparathyroidism. J Bone Miner Res: 2011; 26 2473 2485
67. Li T, Vu T H, Zeng Z L, Nguyen B T, Hayward B E, Bonthron D T, Hu J F, Hoffman A R. Tissue-specific expression of antisense and sense transcripts at the imprinted Gnas locus. Genomics: 2000; 69 295 304
68. Pasolli H, Klemke M, Kehlenbach R, Wang Y, Huttner W. Characterization of the extra-large G protein alpha-subunit XLalphas. I. Tissue distribution and subcellular localization. J Biol Chem: 2000; 275 33622 33632
69. Pasolli H, Huttner W. Expression of the extra-large G protein alpha-subunit XLalphas in neuroepithelial cells and young neurons during development of the rat nervous system. Neurosci Lett: 2001; 301 119 122
70. Liu Z, Segawa H, Aydin C, Reyes M, Erben R G, Weinstein L S, Chen M, Marshansky V, Frohlich L F, Bastepe M. Transgenic Overexpression of the Extra-Large Gs{alpha} Variant XL{alpha}s Enhances Gs{alpha}-Mediated Responses in the Mouse Renal Proximal Tubule in Vivo. Endocrinology: 2011; 152 1222 1233
71. Pignolo R J, Xu M, Russell E, Richardson A, Kaplan J, Billings P C, Kaplan F S, Shore E M. Heterozygous inactivation of Gnas in adipose-derived mesenchymal progenitor cells enhances osteoblast differentiation and promotes heterotopic ossification. J Bone Miner Res: 2011; 26 2647 2655
72. Krechowec S O, Burton K L, Newlaczyl A U, Nunn N, Vlatkovic N, Plagge A. Postnatal Changes in the Expression Pattern of the Imprinted Signalling Protein XLalphas Underlie the Changing Phenotype of Deficient Mice. PLoS One: 2012; 7 e29753
73. Plagge A, Gordon E, Dean W, Boiani R, Cinti S, Peters J, Kelsey G. The imprinted signaling protein XLalphas is required for postnatal adaptation to feeding. Nat Genet: 2004; 36 818 826
74. Michienzi S, Cherman N, Holmbeck K, Funari A, Collins M T, Bianco P, Robey P G, Riminucci M. GNAS transcripts in skeletal progenitors: evidence for random asymmetric allelic expression of Gs{alpha}. Hum Mol Genet: 2007; 16 1921 1930
75. Mariot V, Wu J Y, Aydin C, Mantovani G, Mahon M J, Linglart A, Bastepe M. Potent constitutive cyclic AMP-generating activity of XLalphas implicates this imprinted GNAS product in the pathogenesis of McCune-Albright Syndrome and fibrous dysplasia of bone. Bone: 2011; 48 312 320
76. Xie T, Plagge A, Gavrilova O, Pack S, Jou W, Lai E W, Frontera M, Kelsey G, Weinstein L S. The alternative stimulatory G protein alpha-subunit XLalphas is a critical regulator of energy and glucose metabolism and sympathetic nerve activity in adult mice. J Biol Chem: 2006; 281 18989 18999
77. Klemke M, Pasolli H, Kehlenbach R, Offermanns S, Schultz G, Huttner W. Characterization of the extra-large G protein alpha-subunit XLalphas. II. Signal transduction properties. J Biol Chem: 2000; 275 33633 33640
78. Liu Z, Turan S, Wehbi V L, Vilardaga J P, Bastepe M. Extra-long Galphas variant XLalphas protein escapes activation-induced subcellular redistribution and is able to provide sustained signaling. J Biol Chem: 2011; 286 38558 38569
79. Bastepe M, Gunes Y, Perez-Villamil B, Hunzelman J, Weinstein L S, Jüppner H. Receptor-Mediated Adenylyl Cyclase Activation Through XLalphas, the Extra-Large Variant of the Stimulatory G Protein alpha-Subunit. Mol Endocrinol: 2002; 16 1912 1919
80. Ugur O, Jones T L. A proline-rich region and nearby cysteine residues target XLalphas to the Golgi complex region. Mol Biol Cell: 2000; 11 1421 1432
81. Levis M J, Bourne H R. Activation of the alpha subunit of Gs in intact cells alters its abundance, rate of degradation, and membrane avidity. J Cell Biol: 1992; 119 1297 1307
82. Wedegaertner P B, Bourne H R, von Zastrow M. Activation-induced subcellular redistribution of Gs alpha. Mol Biol Cell: 1996; 7 1225 1233
83. Aydin C, Aytan N, Mahon M J, Tawfeek H A, Kowall N W, Dedeoglu A, Bastepe M. Extralarge XLas (XXLas), a variant of stimulatory G protein alpha-subunit (Gsα), is a distinct, membrane-anchored GNAS product that can mimic Gsa. Endocrinology: 2009; 150 3567 3575
84. Wedegaertner P B, Chu D H, Wilson P T, Levis M J, Bourne H R. Palmitoylation is required for signaling functions and membrane attachment of Gq alpha and Gs alpha. J Biol Chem: 1993; 268 25001 25008
85. Wedegaertner P B, Bourne H R. Activation and depalmitoylation of Gs alpha. Cell: 1994; 77 1063 1070
86. Wedegaertner P B, Wilson P T, Bourne H R. Lipid modifications of trimeric G proteins. J Biol Chem: 1995; 270 503 506
87. Iiri T, Backlund P S Jr, Jones T L, Wedegaertner P B, Bourne H R. Reciprocal regulation of Gs alpha by palmitate and the beta gamma subunit. Proc Natl Acad Sci USA: 1996; 93 14592 14597
88. Evanko D S, Thiyagarajan M M, Wedegaertner P B. Interaction with Gbetagamma is required for membrane targeting and palmitoylation of Galpha(s) and Galpha(q). J Biol Chem: 2000; 275 1327 1336
89. Hughes T E, Zhang H, Logothetis D E, Berlot C H. Visualization of a functional Galpha q-green fluorescent protein fusion in living cells. Association with the plasma membrane is disrupted by mutational activation and by elimination of palmitoylation sites, but not be activation mediated by receptors or AlF4. J Biol Chem: 2001; 276 4227 4235
90. Evanko D S, Thiyagarajan M M, Siderovski D P, Wedegaertner P B. Gbeta gamma isoforms selectively rescue plasma membrane localization and palmitoylation of mutant Galphas and Galphaq. J Biol Chem: 2001; 276 23945 23953
91. Makita N, Sato J, Rondard P, Fukamachi H, Yuasa Y, Aldred M A, Hashimoto M, Fujita T, Iiri T. Human G(salpha) mutant causes pseudohypoparathyroidism type Ia/neonatal diarrhea, a potential cell-specific role of the palmitoylation cycle. Proc Natl Acad Sci USA: 2007; 104 17424 17429
92. Kaya A I, Ugur O, Oner S S, Bastepe M, Onaran H O. Coupling of {beta}2-adrenoceptors to XL{alpha}s and G{alpha}s: A new insight into ligand-induced G protein activation. J Pharmacol Exp Ther: 2009; 329 350 359
93. Bray P, Carter A, Simons C, Guo V, Puckett C, Kamholz J, Spiegel A, Nirenberg M. Human cDNA clones for four species of G alpha s signal transduction protein. Proc Natl Acad Sci USA: 1986; 83 8893 8897
94. Robishaw J D, Smigel M D, Gilman A G. Molecular basis for two forms of the G protein that stimulates adenylate cyclase. J Biol Chem: 1986; 261 9587 9590
95. Crawford J A, Mutchler K J, Sullivan B E, Lanigan T M, Clark M S, Russo A F. Neural expression of a novel alternatively spliced and polyadenylated Gs alpha transcript. J Biol Chem: 1993; 268 9879 9885
96. Abramowitz J, Grenet D, Birnbaumer M, Torres H N, Birnbaumer L. XLalphas the extra-long form of the alpha-subunit of the Gs G protein, is significantly longer than suspected, and so is its companion Alex. Proc Natl Acad Sci USA: 2004; 101 8366 8371
97. Klemke M, Kehlenbach R H, Huttner W B. Two overlapping reading frames in a single exon encode interacting proteins - a novel way of gene usage. Embo J: 2001; 20 3849 3860
98. Freson K, Jaeken J, Van Helvoirt M, de Zegher F, Wittevrongel C, Thys C, Hoylaerts M F, Vermylen J, Van Geet C. Functional polymorphisms in the paternally expressed XLalphas and its cofactor ALEX decrease their mutual interaction and enhance receptor-mediated cAMP formation. Hum Mol Genet: 2003; 12 1121 1130
99. Yu S, Castle A, Chen M, Lee R, Takeda K, Weinstein L S. Increased insulin sensitivity in Gsalpha knockout mice. J Biol Chem: 2001; 276 19994 19998
100. Yu S, Gavrilova O, Chen H, Lee R, Liu J, Pacak K, Parlow A, Quon M, Reitman M, Weinstein L. Paternal versus maternal transmission of a stimulatory G-protein alpha subunit knockout produces opposite effects on energy metabolism. J Clin Invest: 2000; 105 615 623
101. Chen M, Haluzik M, Wolf N J, Lorenzo J, Dietz K R, Reitman M L, Weinstein L S. Increased insulin sensitivity in paternal Gnas knockout mice is associated with increased lipid clearance. Endocrinology: 2004; 145 4094 4102
102. Skinner J, Cattanach B, Peters J. The imprinted oedematous-small mutation on mouse chromosome 2 identifies new roles for gnas and gnasxl in development. Genomics: 2002; 80 373
103. Williamson C M, Ball S T, Nottingham W T, Skinner J A, Plagge A, Turner M D, Powles N, Hough T, Papworth D, Fraser W D, Maconochie M, Peters J. A cis-acting control region is required exclusively for the tissue-specific imprinting of Gnas. Nat Genet: 2004; 36 894 899
104. Kelly M L, Moir L, Jones L, Whitehill E, Anstee Q M, Goldin R D, Hough A, Cheeseman M, Jansson J O, Peters J, Cox R D. A missense mutation in the non-neural G-protein alpha-subunit isoforms modulates susceptibility to obesity. Int J Obes (Lond): 2009; 33 507 518
105. Eaton S A, Williamson C M, Ball S T, Beechey C V, Moir L, Edwards J, Teboul L, Maconochie M, Peters J. New Mutations at the Imprinted Gnas Cluster Show Gene Dosage Effects of Gsalpha in Postnatal Growth and Implicate XLalphas in Bone and Fat Metabolism but Not in Suckling. Mol Cell Biol: 2012; 32 1017 1029
106. Chen M, Gavrilova O, Liu J, Xie T, Deng C, Nguyen A T, Nackers L M, Lorenzo J, Shen L, Weinstein L S. Alternative Gnas gene products have opposite effects on glucose and lipid metabolism. Proc Natl Acad Sci USA: 2005; 102 7386 7391
107. Germain-Lee E L, Schwindinger W, Crane J L, Zewdu R, Zweifel L S, Wand G, Huso D L, Saji M, Ringel M D, Levine M A. A Mouse Model of Albright Hereditary Osteodystrophy Generated by Targeted Disruption of Exon 1 of the Gnas Gene. Endocrinology: 2005; 146 4697 4709
108. Genevieve D, Sanlaville D, Faivre L, Kottler M L, Jambou M, Gosset P, Boustani-Samara D, Pinto G, Ozilou C, Abeguile G, Munnich A, Romana S, Raoul O, Cormier-Daire V, Vekemans M. Paternal deletion of the GNAS imprinted locus (including Gnasxl) in two girls presenting with severe pre- and post-natal growth retardation and intractable feeding difficulties. Eur J Hum Genet: 2005; 13 1033 1039
109. Aldred M A, Aftimos S, Hall C, Waters K S, Thakker R V, Trembath R C, Brueton L. Constitutional deletion of chromosome 20q in two patients affected with albright hereditary osteodystrophy. Am J Med Genet: 2002; 113 167 172
110. Chudoba I, Franke Y, Senger G, Sauerbrei G, Demuth S, Beensen V, Neumann A, Hansmann I, Claussen U. Maternal UPD 20 in a hyperactive child with severe growth retardation. Eur J Hum Genet: 1999; 7 533 540
111. Lebrun M, Richard N, Abeguile G, David A, Coeslier Dieux A, Journel H, Lacombe D, Pinto G, Odent S, Salles J P, Taieb A, Gandon-Laloum S, Kottler M L. Progressive osseous heteroplasia: a model for the imprinting effects of GNAS inactivating mutations in humans. J Clin Endocrinol Metab: 2010; 95 3028 3038
112. Kaplan F S, Shore E M. Progressive osseous heteroplasia. J Bone Miner Res: 2000; 15 2084 2094
113. Shore E M, Ahn J, Jan de Beur S, Li M, Xu M, Gardner R J, Zasloff M A, Whyte M P, Levine M A, Kaplan F S. Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia. N Engl J Med: 2002; 346 99 106
114. Faust R A, Shore E M, Stevens C E, Xu M, Shah S, Phillips C D, Kaplan F S. Progressive osseous heteroplasia in the face of a child. Am J Med Genet A: 2003; 118 71 75
115. Chan I, Hamada T, Hardman C, McGrath J A, Child F J. Progressive osseous heteroplasia resulting from a new mutation in the GNAS1 gene. Clin Exp Dermatol: 2004; 29 77 80
116. Adegbite N S, Xu M, Kaplan F S, Shore E M, Pignolo R J. Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification. Am J Med Genet A: 2008; 146A 1788 1796
117. Mantovani G, Bondioni S, Lania A G, Corbetta S, de Sanctis L, Cappa M, Di Battista E, Chanson P, Beck-Peccoz P, Spada A. Parental origin of Gsalpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors. J Clin Endocrinol Metab: 2004; 89 3007 3009
118. Cattanach B M, Peters J, Ball S, Rasberry C. Two imprinted gene mutations: three phenotypes. Hum Mol Genet: 2000; 9 2263 2273